Targeting EETs to treat cardiovascular disease may prove a double-edged sword
Monday, December 19, 2011 - 12:20
in Health & Medicine
A group of small molecules called EETs currently under scrutiny as possible treatment targets for a host of cardiovascular diseases may also drive the growth and spread of cancer, according to researchers at the Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) and other institutions. Their findings also raise the possibility that drugs that block EETs could serve as a new avenue for cancer treatment.